Cabinet Allergy Relief Refill Cetirizine Hci Tablet
NDC Package 82725-3003-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Cabinet Allergy Relief Refill Cetirizine Hci (cetirizine hydrochloride) tablets is  adults & children 6 years & over one 10 mg caplet once daily; do not take more than one 10 mg caplet in 24 hours. This formulation utilizes a tablet delivery system. Marketed by Cabinet Health P.b.c., this product is identified by NDC 82725-3003 and is authorized under FDA application ANDA077829.

Identification & Billing

NDC Package Code
82725-3003-2
Package Description
40 TABLET in 1 POUCH
Product Code
11-Digit Billing Format
82725300302
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Cabinet Allergy Relief Refill Cetirizine Hci
Non-Proprietary Name
Cetirizine Hydrochloride
Substance Name
Cetirizine Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
 adults & children 6 years & over one 10 mg caplet once daily; do not take more than one 10 mg caplet in 24 hours. A 5 mg product may be appropriate for less severe symptoms  adults 65 years & over ask a doctor children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Regulatory & Marketing

Labeler Name
Cabinet Health P.b.c.
Product Type
Human Otc Drug
FDA Application #
ANDA077829
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-25-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82725-3003-2 identifies a specific commercial package of 40 tablet in 1 pouch of Cabinet Allergy Relief Refill Cetirizine Hci, a human over the counter drug labeled by Cabinet Health P.b.c.. This tablet is formulated for oral use and contains cetirizine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cabinet Health P.b.c. on June 25, 2025. The current certification is valid through December 31, 2026.

How is this Cabinet Health P.b.c. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82725300302. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
82725-3003-2
11-Digit CMS (5-4-2)
82725-3003-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.